The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review

被引：140

作者：

Shiro, Tomoya ^{[1
]}

Fukaya, Takayuki ^{[1
]}

Tobe, Masanori ^{[1
]}

机构：

[1] Sumitomo Dainippon Pharma Co Ltd, Drug Res Div, Suita, Osaka 5640053, Japan

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 97卷

关键词：

Quinolinone; Quinolin-4-one; Heterocycles; MUSCARINIC ACETYLCHOLINE-RECEPTORS; PROSTAGLANDIN E-2 SYNTHASE; PEPTIDASE-IV INHIBITOR; POSITIVE ALLOSTERIC MODULATOR; GLUCAGON-LIKE PEPTIDE-1; HIGHLY POTENT; MICE LACKING; DISCOVERY; HEDGEHOG; AMPA;

D O I：

10.1016/j.ejmech.2014.12.004

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Among all heterocycles, the heterocycle-fused quinolinone scaffold is one of the privileged structures in drug discovery as heterocycle-fused quinolinone derivatives exhibit various biological activities allowing them to act as anti-inflammatory, anticancer, antidiabetic, and antipsychotic agents. This wide spectrum of biological activity has attracted a great deal of attention in the field of medicinal chemistry. In this review, we provide a comprehensive description of the biological and pharmacological properties of various heterocycle-fused quinolinone scaffolds and discuss the synthetic methods of some of their derivatives. (C) 2014 Elsevier Masson SAS. All rights reserved.

引用

页码：397 / 408

页数：12

共 77 条

[31] Human homolog of patched, a candidate gene for the basal cell nevus syndrome [J].

Johnson, RL ;

Rothman, AL ;

Xie, JW ;

Goodrich, LV ;

Bare, JW ;

Bonifas, JM ;

Quinn, AG ;

Myers, RM ;

Cox, DR ;

Epstein, EH ;

Scott, MP .

SCIENCE, 1996, 272 (5268) :1668-1671

[32] Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1 [J].

Kamei, D ;

Yamakawa, K ;

Takegoshi, Y ;

Mikami-Nakanishi, M ;

Nakatani, Y ;

Oh-ishi, S ;

Yasui, H ;

Azuma, Y ;

Hirasawa, N ;

Ohuchi, K ;

Kawaguchi, H ;

Ishikawa, Y ;

Ishii, T ;

Uematsu, S ;

Akira, S ;

Murakami, M ;

Kudo, I .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33684-33695

[33] (2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes [J].

Kim, D ;

Wang, LP ;

Beconi, M ;

Eiermann, GJ ;

Fisher, MH ;

He, HB ;

Hickey, GJ ;

Kowalchick, JE ;

Leiting, B ;

Lyons, K ;

Marsilio, F ;

McCann, ME ;

Patel, RA ;

Petrov, A ;

Scapin, G ;

Patel, SB ;

Roy, RS ;

Wu, JK ;

Wyvratt, MJ ;

Zhang, BB ;

Zhu, L ;

Thornberry, NA ;

Weber, AE .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :141-151

[34] Glucagon-like peptide-1: The basis of a new class of treatment for type 2 diabetes [J].

Knudsen, LB .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) :4128-4134

[35] Muscarinic acetylcholine receptors: novel opportunities for drug development [J].

Kruse, Andrew C. ;

Kobilka, Brian K. ;

Gautam, Dinesh ;

Sexton, Patrick M. ;

Christopoulos, Arthur ;

Wess, Juergen .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (07) :549-560

[36] IDENTIFICATION AND EFFICIENT SYNTHESIS OF 6-METHOXY-2-BENZOXAZOLINONE (MBOA), AN INSECT ANTIFEEDANT [J].

KUBO, I ;

KAMIKAWA, T .

EXPERIENTIA, 1983, 39 (04) :355-355

[37] Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: Development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia [J].

Le, Uyen ;

Melancon, Bruce J. ;

Bridges, Thomas M. ;

Vinson, Paige N. ;

Utley, Thomas J. ;

Lamsal, Atin ;

Rodriguez, Alice L. ;

Venable, Daryl ;

Sheffler, Douglas J. ;

Jones, Carrie K. ;

Blobaum, Anna L. ;

Wood, Michael R. ;

Daniels, J. Scott ;

Conn, P. Jeffrey ;

Niswender, Colleen M. ;

Lindsley, Craig W. ;

Hopkins, Corey R. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) :346-350

[38]

Lu YF, 1999, J NEUROSCI, V19, P10250

[39] The Hedgehog response network: Sensors, switches, and routers [J].

Lum, L ;

Beachy, PA .

SCIENCE, 2004, 304 (5678) :1755-1759

[40] Membrane-associated prostaglandin E synthase-I is required for neuropathic pain [J].

Mabuchi, T ;

Kojima, H ;

Abe, T ;

Takagi, K ;

Sakurai, M ;

Ohmiya, Y ;

Uematsu, S ;

Akira, S ;

Watanabe, K ;

Ito, S .

NEUROREPORT, 2004, 15 (09) :1395-1398

← 1 2 3 4 5 6 7 8 →